大博医疗收盘上涨1.59%，滚动市盈率73.73倍，总市值148.30亿元

Group 1 - The core viewpoint of the news is that Dabo Medical's stock performance shows a significant increase in net profit and revenue, despite a high PE ratio compared to industry averages [1] - As of April 2, Dabo Medical's closing price was 35.82 yuan, with a PE ratio of 73.73, marking a new low in 44 days, and a total market capitalization of 14.83 billion yuan [1] - The medical device industry has an average PE ratio of 46.88, with a median of 33.67, placing Dabo Medical at the 103rd position in the industry ranking [1][2] Group 2 - Dabo Medical's main business includes the production, research, and sales of high-value medical consumables, with key products in orthopedic trauma, spinal, joint, sports medicine, neurosurgery, minimally invasive surgery, and dental implants [1] - The latest financial results for the third quarter of 2024 show that the company achieved a revenue of 1.529 billion yuan, a year-on-year increase of 35.88%, and a net profit of 240 million yuan, a year-on-year increase of 145.48%, with a gross profit margin of 68.47% [1]